Humacyte, Inc. (HUMA)
1.02
+0.10
(+11.21%)
USD |
NASDAQ |
May 21, 16:00
1.02
0.00 (0.00%)
After-Hours: 17:13
Humacyte Total Liabilities (Quarterly) : 98.93M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 51.64M |
| Vertex Pharmaceuticals, Inc. | 7.122B |
| PDS Biotechnology Corp. | 20.77M |
| Bolt Biotherapeutics, Inc. | 28.20M |
| Entrada Therapeutics, Inc. | 64.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.56M |
| Shareholders Equity (Quarterly) | 11.62M |
| Debt to Equity Ratio | 5.669 |
| Current Ratio | 3.929 |
| Net Debt Paydown Yield | 2.17% |